Dishman Carbogen Amc
Ticker > Company >

Dishman Carbogen Amc share price

Dishman Carbogen Amcis Ltd.

NSE: DCAL BSE: 540701 SECTOR: Pharmaceuticals & Drugs  1.08 L   204   20

265.00
+1.10 (0.42%)
BSE: 29 Aug 04:01 PM

Price Summary

Today's High

₹ 272.9

Today's Low

₹ 262.15

52 Week High

₹ 307.8

52 Week Low

₹ 161.35

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 4154.75 Cr.

Enterprise Value

₹ 4668.83 Cr.

No. of Shares

15.68 Cr.

P/E

0

P/B

1.03

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  257.24

CASH

₹ 9.9 Cr.

DEBT

₹ 523.98 Cr.

Promoter Holding

59.32 %

EPS (TTM)

₹  -0.24

Sales Growth

-18.68%

ROE

-1.87 %

ROCE

-0.75%

Profit Growth

-29.79 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-18.68%
3 Year17.79%
5 Year-9.84%

Profit Growth

1 Year-29.79%
3 Year18.68%
5 Year-206.41%

ROE%

1 Year-1.87%
3 Year-1.32%
5 Year-1.59%

ROCE %

1 Year-0.75%
3 Year-0.83%
5 Year-0.6%

Debt/Equity

0.1293

Price to Cash Flow

171.9

Interest Cover Ratio

-0.5105

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 59.32 0.00
Mar 2025 59.32 0.00
Dec 2024 59.32 0.00
Sep 2024 59.32 0.00
Jun 2024 59.32 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 18.4550077204938% for the Past 3 years.
  • The company has shown a good revenue growth of 17.7864412208737% for the Past 3 years.
  • The company has an efficient Cash Conversion Cycle of 63.9983 days.
  • The company has a high promoter holding of 59.32%.

 Limitations

  • Company has a poor ROE of -1.32204235755562% over the past 3 years.
  • Company has a poor ROCE of -0.828211859911797% over the past 3 years
  • Company has low Interest coverage ratio of -0.5105.
  • Company has high debtor days of 184.2561.
  • The company has a low EBITDA margin of 3.7117373409443% over the past 5 years.
  • The company is trading at a high EV/EBITDA of 39.6932.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 103.41 93.29 97.04 106.1 62.86
Total Expenditure 88.51 79.89 74.08 85.57 59.43
Operating Profit 14.9 13.4 22.96 20.53 3.43
Other Income 11.59 23.93 -8.01 5.47 37.42
Interest 15.73 15.59 17.77 21.31 20.26
Depreciation 16.32 16.3 16.48 16.1 16.47
Exceptional Items 0 0 0 0 0
Profit Before Tax -5.56 5.44 -19.3 -11.41 4.12
Tax -2.09 -8.81 -6.02 -4.04 1.45
Profit After Tax -3.47 14.25 -13.28 -7.37 2.67
Adjusted EPS (Rs) -0.22 0.91 -0.85 -0.47 0.17

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 580.74 200.32 306.61 402.55 327.35
Total Expenditure 407.18 253.11 272.82 394.79 320.55
Operating Profit 173.56 -52.79 33.79 7.76 6.8
Other Income 69.57 66.29 66.11 52.16 63.05
Interest 47.02 34.17 37.23 57.92 68.19
Depreciation 140.65 141.35 140.07 96.2 101.61
Exceptional Items 0 0 -5.91 -2 -3.05
Profit Before Tax 55.46 -162.02 -83.31 -96.2 -103
Tax 16.94 64.12 -52.84 -37.33 -26.59
Net Profit 38.52 -232.81 -31.55 -58.87 -76.41
Adjusted EPS (Rs.) 2.46 -14.42 -1.94 -3.75 -4.87

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 31.38 31.36 31.36 31.36 31.36
Total Reserves 4764.47 4643.26 4200.42 4082.95 4021.22
Borrowings 137.9 144.41 134.42 162.57 157.37
Other N/C liabilities 356.7 348.96 444.04 409.68 395.1
Current liabilities 620.44 530.88 551.19 641.6 618.73
Total Liabilities 5910.89 5698.87 5361.43 5328.16 5223.78
Assets
Net Block 1632.53 1509.65 1355.98 1382.3 1415.63
Capital WIP 57.14 79.36 114.12 141.88 73.35
Intangible WIP 31.71 41.84 3.65 1.01 0.7
Investments 2843.1 2814.87 2811.09 2837.36 2834.26
Loans & Advances 576.27 529.74 310.14 315.19 311.95
Other N/C Assets 5.45 0.35 0.66 0.81 0.67
Current Assets 764.69 723.06 765.79 649.61 587.22
Total Assets 5910.89 5698.87 5361.43 5328.16 5223.78
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 55.46 -168.69 -84.39 -96.2 -103
Adjustment 135.32 128.11 117.32 100.96 116.86
Changes in Assets & Liabilities 24.14 46.25 200.55 -54.11 11.53
Tax Paid -18.24 -7.18 -6.13 -3.55 -1.22
Operating Cash Flow 196.68 -1.51 227.35 -52.9 24.17
Investing Cash Flow -74.3 62.07 -172.67 40.71 96.57
Financing Cash Flow -124.07 -70.53 -46.16 1.38 -130.76
Net Cash Flow -1.69 -9.97 8.52 -10.81 -10.02

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 59.32 59.32 59.32 59.32 59.32
adimans technologies llp ... - - - - 59.32
adimans technologies llp 59.32 59.32 59.32 59.32 -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 40.68 40.68 40.68 40.68 40.68
hbm healthcare investment... 3.55 3.55 3.55 3.57 3.57
investor education and pr... - 0.02 0.02 0.02 0.02
llp 0.39 0.30 0.81 0.79 0.73
massachusetts institute o... 1.95 1.95 1.95 2.27 2.28
mukul mahavir agrawal 5.74 5.50 5.50 5.50 5.50
investor education and pr... 0.02 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit FITCH
Credit FITCH
Credit INDIA RATINGS & RESEARCH
Credit FITCH
Credit FITCH
TYPE AGENCY Link
TYPE AGENCY Link
Research HDFC Securities
Research BOB Capital Market
Research Nirmal Bang Institutional
Research HDFC Securities

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY22
Concall Q3FY24
Concall Q3FY24
Concall Q3FY23
Concall Q1FY25
Concall Q1FY24
Concall Q1FY23
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY21
Presentation Q4FY20
Presentation Q3FY24
Presentation Q3FY22
Presentation Q3FY21
Presentation Q2FY22
Presentation Q2FY21
Presentation Q1FY22
Presentation Q1FY21

Company News

Dishman Carbogen Amcis receives EIR from USFDA 28 Aug, 12:59 PM Dishman Carbogen Amc - Quaterly Results 12 Aug, 10:44 PM Dishman Carbogen Amc - Quaterly Results 12 Aug, 10:44 PM USFDA completes inspection at Dishman Carbogen Amcis’ facility in Naroda 16 Jun, 9:48 AM Dishman Carbogen Amcis’ arm enters into co-investment agreement with Japanese customer 6 Jun, 3:47 PM Dishman Carbogen Amcis informs about press release 26 May, 5:44 PM Dishman Carbogen Amc - Quaterly Results 21 May, 11:12 PM Dishman Carbogen Amc - Quaterly Results 21 May, 11:12 PM Dishman Carbogen Amcis’ arm gets drug manufacturing license from NMPA for Shanghai facility 22 Apr, 11:52 AM Dishman Carbogen Amcis raises Rs 50 crore through NCDs 26 Mar, 3:51 PM Dishman Carbogen Amcis’ arm receives Certificate of GMP Compliance form ANSM 20 Mar, 1:00 PM Dishman Carbogen Amc - Quaterly Results 12 Feb, 8:05 PM Dishman Carbogen Amc - Quaterly Results 12 Feb, 8:05 PM Dishman Carbogen Amcis’ arm completes Swissmedic inspection of Vionnaz facility 10 Jan, 2:58 PM Dishman Carbogen Amcis informs about presentation 14 Nov, 9:44 AM Dishman Carbogen Amc - Quaterly Results 13 Nov, 11:42 PM Dishman Carbogen Amc - Quaterly Results 13 Nov, 11:42 PM Dishman Carbogen Amcis informs about confirmation certificate 10 Oct, 5:08 PM Dishman Carbogen Amcis informs about closure of trading window 25 Sep, 5:21 PM Dishman Carbogen Amcis informs about closure of trading window 25 Sep, 5:14 PM Dishman Carbogen Amcis informs about earnings call transcript 22 Aug, 5:18 PM Dishman Carbogen Amc - Quaterly Results 13 Aug, 8:30 PM Dishman Carbogen Amc - Quaterly Results 30 May, 11:40 PM Dishman Carbogen Amc - Quaterly Results 30 May, 11:40 PM Dishman Carbogen Amcis planning to raise funds via NCDS 25 May, 2:02 PM Dishman Carbogen Amc - Quaterly Results 14 Feb, 7:01 PM Dishman Carbogen Amc - Quaterly Results 14 Feb, 7:01 PM Dishman Carbogen Amcis informs about disclosure 3 Feb, 1:46 PM Dishman Carbogen Amc - Quaterly Results 8 Nov, 7:21 PM Dishman Carbogen Amc - Quaterly Results 8 Nov, 7:21 PM Dishman Carbogen Amcis informs about closure of trading window 22 Sep, 5:19 PM Dishman Carbogen Amc - Quaterly Results 9 Aug, 6:12 PM Dishman Carbogen Amc - Quaterly Results 9 Aug, 6:12 PM Dishman Carbogen Amc - Quaterly Results 23 May, 4:57 PM Dishman Carbogen Amc - Quaterly Results 23 May, 4:57 PM Dishman Carbogen Amcis informs about board meeting 15 May, 5:16 PM Dishman Carbogen Amcis’ arm completes USFDA’s inspection at Switzerland manufacturing site 16 Feb, 4:58 PM Dishman Carbogen Amcis informs about transcript of earnings call 15 Feb, 4:32 PM Dishman Carbogen Amc - Quaterly Results 10 Feb, 4:12 PM Dishman Carbogen Amc - Quaterly Results 10 Feb, 4:12 PM Dishman Carbogen Amc - Quaterly Results 10 Feb, 4:12 PM Dishman Carbogen Amcis informs about board meeting 12 Jan, 4:48 PM Dishman Carbogen Amcis informs about credit rating 22 Dec, 3:25 PM Dishman Carbogen Amc - Quaterly Results 11 Nov, 3:47 PM Dishman Carbogen Amc - Quaterly Results 11 Nov, 3:47 PM Dishman Carbogen Amcis’ arm completes Swissmedic inspection of facility in Switzerland 29 Sep, 12:17 PM Dishman Carbogen Amcis informs about conference call 10 Aug, 4:58 PM Dishman Carbogen Amcis informs about investor presentation 10 Aug, 12:25 PM Dishman Carbogen Amc - Quaterly Results 9 Aug, 6:39 PM Dishman Carbogen Amc - Quaterly Results 9 Aug, 6:39 PM

Dishman Carbogen Amc Stock Price Analysis and Quick Research Report. Is Dishman Carbogen Amc an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Dishman Carbogen Amc. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Dishman Carbogen Amc has a PE ratio of -1112.23203026482 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Dishman Carbogen Amc has ROA of -1.4483% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Dishman Carbogen Amc has a Current ratio of 0.9491.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Dishman Carbogen Amc has a ROE of -1.8712%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Dishman Carbogen Amc has a Debt to Equity ratio of 0.1293 which means that the company has low proportion of debt in its capital.

  • Sales growth: Dishman Carbogen Amc has reported revenue growth of -18.6809% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Dishman Carbogen Amc for the current financial year is 2.07728730716359%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Dishman Carbogen Amc is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Dishman Carbogen Amc is Rs -0.2379. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Dishman Carbogen Amc in Ticker for free. Also, one can get the intrinsic value of Dishman Carbogen Amc by using Valuation Calculators, which are available with a Finology ONE subscription. 

Dishman Carbogen Amc FAQs

Q1. What is Dishman Carbogen Amc share price today?
Ans: The current share price of Dishman Carbogen Amc is Rs 264.6.

Q2. What is the market capitalisation of Dishman Carbogen Amc?
Ans: Dishman Carbogen Amc has a market capitalisation of Rs 4148.4806937 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Dishman Carbogen Amc?
Ans: The PE ratio of Dishman Carbogen Amc is -1112.23203026482 and the P/B ratio of Dishman Carbogen Amc is 1.0285966186927, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Dishman Carbogen Amc share?
Ans: The 52-week high share price of Dishman Carbogen Amc is Rs 307.98, and the 52-week low share price of Dishman Carbogen Amc is Rs 161.21.

Q5. Does Dishman Carbogen Amc pay dividends?
Ans: Currently, Dishman Carbogen Amc does not pay dividends. Dividend yield of Dishman Carbogen Amc is around 0%.

Q6. What are the face value and book value of Dishman Carbogen Amc shares?
Ans: The face value of Dishman Carbogen Amc shares is Rs 2, while the book value per share of Dishman Carbogen Amc is around Rs 257.2437. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Dishman Carbogen Amc?
Ans: Dishman Carbogen Amc has a total debt of Rs 523.98 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Dishman Carbogen Amc?
Ans: The ROE of Dishman Carbogen Amc is -1.8712% and ROCE of Dishman Carbogen Amc is -0.7502%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Dishman Carbogen Amc a good buy for the long term?
Ans: The Dishman Carbogen Amc long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Dishman Carbogen Amc undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Dishman Carbogen Amc appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Dishman Carbogen Amc’s financials?
Ans: You can review Dishman Carbogen Amc’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Dishman Carbogen Amc

Dishman Carbogen Amcis Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Dishman Carbogen Amcis Ltd. is a leading global contract research and manufacturing organization (CRMO) that focuses on the development and manufacturing of intermediates, APIs (active pharmaceutical ingredients), and finished dosage forms. With a rich history spanning several decades, Dishman Carbogen Amcis has established itself as a trusted partner in the pharmaceutical and life sciences industry.

Dishman Carbogen Amcis Ltd. - Share Price

Explore the latest share price of Dishman Carbogen Amcis Ltd. and track its performance in the stock market. Our website offers a user-friendly interface that allows you to stay updated with real-time stock prices, historical data, and key performance indicators.

Dishman Carbogen Amcis Ltd. - Balance Sheet

Gain insights into Dishman Carbogen Amcis Ltd.'s financial position through a comprehensive analysis of its balance sheet. Assess the company's assets, liabilities, and shareholders' equity to evaluate its overall financial health.

Dishman Carbogen Amcis Ltd. - Annual Report

Access Dishman Carbogen Amcis Ltd.'s annual reports on our website to review their performance throughout the year. These reports provide a detailed overview of the company's operations, financial results, and strategic initiatives. Stay informed about the company's achievements, challenges, and future prospects.

Dishman Carbogen Amcis Ltd. - Dividend

Discover Dishman Carbogen Amcis Ltd.'s dividend history and track the company's dividend payouts over time. Our website provides dividend information, including the dividend yield and dividend payment dates, enabling you to make informed investment decisions.

Dishman Carbogen Amcis Ltd. - Quarterly Result

Stay updated with Dishman Carbogen Amcis Ltd.'s quarterly results and analyze the company's financial performance for each reporting period. Our website offers downloadable quarterly reports that provide a comprehensive overview of the company's revenue, expenses, and profitability.

Dishman Carbogen Amcis Ltd. - Stock Price

Monitor Dishman Carbogen Amcis Ltd.'s stock price and track its movement in the market. Our website offers interactive stock charts and technical analysis tools to help you analyze historical price trends and make informed investment decisions.

Dishman Carbogen Amcis Ltd. - Price Chart

Our website provides detailed price charts for Dishman Carbogen Amcis Ltd., allowing you to visualize the stock's price movement over different timeframes. Analyze historical price patterns, spot trends, and identify potential investment opportunities using our pre-built screening tools.

Dishman Carbogen Amcis Ltd. - News

Stay informed about recent developments and news related to Dishman Carbogen Amcis Ltd. Our website curates the latest news articles and press releases, providing you with up-to-date information on the company's activities, collaborations, regulatory updates, and more.

Dishman Carbogen Amcis Ltd. - Concall Transcripts

Access Dishman Carbogen Amcis Ltd.'s con call transcripts on our website. These transcripts provide detailed insights into the company's conference calls with investors, allowing you to understand the management's perspective on the company's performance, future plans, and industry trends.

Dishman Carbogen Amcis Ltd. - Investor Presentations

Explore Dishman Carbogen Amcis Ltd.'s investor presentations to gain deeper insights into the company's strategy, market positioning, and growth potential. Our website provides downloadable investor presentations that showcase the company's achievements, financial highlights, and future outlook.

Dishman Carbogen Amcis Ltd. - Promoters

Learn about Dishman Carbogen Amcis Ltd.'s promoters and their contribution to the company's growth and success. Understand their vision, leadership, and strategic direction, which play a crucial role in shaping the company's future.

Dishman Carbogen Amcis Ltd. - Shareholders

Explore Dishman Carbogen Amcis Ltd.'s shareholder structure and understand the ownership pattern of the company. Gain insights into the major shareholders, institutional investors, and public investors who hold shares in Dishman Carbogen Amcis Ltd.

At our website, we offer pre-built screening tools that enable long-term stock investors to perform detailed stock analysis. Our tools, such as DCF analysis, BVPS analysis, earnings multiple approach, and DuPont analysis, allow you to calculate fair value, assess the company's financial health, and make informed investment decisions.

Furthermore, we provide downloadable annual reports, concall transcripts, investor presentations, credit ratings, and research reports for Dishman Carbogen Amcis Ltd., ensuring that you have access to comprehensive information to aid your stock analysis.

Please note that the content is written in a technical tone to cater to the needs of long-term stock investors seeking in-depth stock analysis. 

Dishman Carbogen Amcis Balance Sheet Analysis

Dishman Carbogen Amcis Equity and Liabilities

Analyzing the balance sheet of Dishman Carbogen Amcis, we notice a slight decrease in the company's total liabilities from Rs. 5,910.89 Cr. in March 2020 to Rs. 5,223.78 Cr. by March 2024. The share capital remains stable at Rs. 31.36 Cr. from March 2021 onwards. However, there's a noticeable decline in total reserves, reducing from Rs. 4,764.47 Cr. in March 2020 to Rs. 4,021.22 Cr. by March 2024. Borrowings and other non-current liabilities exhibit fluctuation but demonstrate a decrease in the forecasted year 2024 compared to 2020.

Dishman Carbogen Amcis Assets

On the asset front, Dishman Carbogen Amcis's total assets decreased alongside their liabilities, signifying a balance. The net block and capital work in progress (WIP) reflect a downward trend initially but pick up by March 2023. However, intangible WIP drops significantly by March 2024. Investments remain relatively stable around Rs. 2,800 Cr., indicating cautious financial management. Current assets have seen a decline from Rs. 764.69 Cr. in March 2020 to Rs. 587.22 Cr. by March 2024, signaling a potential reevaluation of liquidity strategies.

This analysis reflects on the standalone balance sheet of Dishman Carbogen Amcis and aids in understanding its financial posture without delving into buy or sell recommendations. It's crucial for investors to examine such data when screening stocks or looking into sectors that the company operates within, including any related to NSE BSE indices or IPOs.

Read More
X